The pathobiology and treatment of Hodgkin lymphoma. Where do we go from Gianni Bonadonna's lesson?

Research output: Contribution to journalArticle

Abstract

This article reviews the evolution of the diagnosis and treatment of Hodgkin lymphoma (HL) since its discovery in 1832. The morphological, phenotypic and molecular characteristics of both nodular lymphocyte-predominant HL and classical HL are revised in the light of recent molecular information and possible impact on the identification of risk groups as well as the use of targeted therapies. The seminal contribution of Gianni Bonadonna to developing new treatment strategies for both advanced and early-stage HL is highlighted.
Original languageUndefined/Unknown
Pages (from-to)101-113
Number of pages13
JournalTumori
Volume103
Issue number2
DOIs
Publication statusPublished - Mar 1 2017

Cite this

@article{32e0b37e30724ee58f17ddfff871bcd5,
title = "The pathobiology and treatment of Hodgkin lymphoma. Where do we go from Gianni Bonadonna's lesson?",
abstract = "This article reviews the evolution of the diagnosis and treatment of Hodgkin lymphoma (HL) since its discovery in 1832. The morphological, phenotypic and molecular characteristics of both nodular lymphocyte-predominant HL and classical HL are revised in the light of recent molecular information and possible impact on the identification of risk groups as well as the use of targeted therapies. The seminal contribution of Gianni Bonadonna to developing new treatment strategies for both advanced and early-stage HL is highlighted.",
author = "Simonetta Viviani and Valentina Tabanelli and Pileri, {Stefano A.}",
year = "2017",
month = "3",
day = "1",
doi = "10.5301/tj.5000608",
language = "Non definita",
volume = "103",
pages = "101--113",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - The pathobiology and treatment of Hodgkin lymphoma. Where do we go from Gianni Bonadonna's lesson?

AU - Viviani, Simonetta

AU - Tabanelli, Valentina

AU - Pileri, Stefano A.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - This article reviews the evolution of the diagnosis and treatment of Hodgkin lymphoma (HL) since its discovery in 1832. The morphological, phenotypic and molecular characteristics of both nodular lymphocyte-predominant HL and classical HL are revised in the light of recent molecular information and possible impact on the identification of risk groups as well as the use of targeted therapies. The seminal contribution of Gianni Bonadonna to developing new treatment strategies for both advanced and early-stage HL is highlighted.

AB - This article reviews the evolution of the diagnosis and treatment of Hodgkin lymphoma (HL) since its discovery in 1832. The morphological, phenotypic and molecular characteristics of both nodular lymphocyte-predominant HL and classical HL are revised in the light of recent molecular information and possible impact on the identification of risk groups as well as the use of targeted therapies. The seminal contribution of Gianni Bonadonna to developing new treatment strategies for both advanced and early-stage HL is highlighted.

U2 - 10.5301/tj.5000608

DO - 10.5301/tj.5000608

M3 - Articolo

VL - 103

SP - 101

EP - 113

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 2

ER -